Efficacy of Hybrid Tetrahydrobenzo[d]thiazole Based Aryl Piperazines D-264 and D-301 at D2 and D3 Receptors

Juan Zhen, Tamara Antonio, Joanna C. Jacob, David Grandy, Maarten E A Reith, Aloke K. Dutta, Dana E. Selley

    Research output: Contribution to journalArticle

    2 Citations (Scopus)

    Abstract

    In elucidating the role of pharmacodynamic efficacy at D3 receptors in therapeutic effectiveness of dopamine receptor agonists, the influence of study system must be understood. Here two compounds with D3 over D2 selectivity developed in our earlier work, D-264 and D-301, are compared in dopamine receptor-mediated G-protein activation in striatal regions of wild-type and D2 receptor knockout mice and in CHO cells expressing D2 or D3 receptors. In caudate-putamen of D2 knockout mice, D-301 was ~3-fold more efficacious than D-264 in activating G-proteins as assessed by [35S]GTPγS binding; in nucleus accumbens, D-301 stimulated G-protein activation whereas D-264 did not. In contrast, the two ligands exerted similar efficacy in both regions of wild-type mice, suggesting both ligands activate D2 receptors with similar efficacy. In D2 and D3 receptor-expressing CHO cells, D-264 and D-301 appeared to act in the [35S]GTPγS assay as full agonists because they produced maximal stimulation equal to dopamine. Competition for [3H]spiperone binding was then performed to determine Ki/EC50 ratios as an index of receptor reserve for each ligand. Action of D-301, but not D-264, showed receptor reserve in D3 but not in D2 receptor-expressing cells, whereas dopamine showed receptor reserve in both cell lines. Gαo1 is highly expressed in brain and is important in D2-like receptor-G protein coupling. Transfection of Gαo1 in D3- but not D2-expressing CHO cells led to receptor reserve for D-264 without altering receptor expression levels. D-301 and dopamine exhibited receptor reserve in D3-expressing cells both with and without transfection of Gαo1. Altogether, these results indicate that D-301 has greater intrinsic efficacy to activate D3 receptors than D-264, whereas the two compounds act on D2 receptors with similar intrinsic efficacy. These findings also suggest caution in interpreting Emax values from functional assays in receptor-transfected cell models without accounting for receptor reserve.

    Original languageEnglish (US)
    Pages (from-to)1-12
    Number of pages12
    JournalNeurochemical Research
    DOIs
    StateAccepted/In press - Dec 31 2015

    Fingerprint

    Piperazines
    Thiazoles
    GTP-Binding Proteins
    CHO Cells
    Dopamine Receptors
    Ligands
    Knockout Mice
    Transfection
    Assays
    Chemical activation
    Pharmacodynamics
    Corpus Striatum
    Spiperone
    Putamen
    Dopamine Agonists
    Nucleus Accumbens
    benzoxonium chloride
    Dopamine
    Brain
    Cells

    Keywords

    • D
    • D
    • Dopamine receptors
    • G protein
    • Gα1
    • Intrinsic efficacy
    • Rat tissue
    • [S]GTPγS binding assay

    ASJC Scopus subject areas

    • Cellular and Molecular Neuroscience
    • Biochemistry

    Cite this

    Zhen, J., Antonio, T., Jacob, J. C., Grandy, D., Reith, M. E. A., Dutta, A. K., & Selley, D. E. (Accepted/In press). Efficacy of Hybrid Tetrahydrobenzo[d]thiazole Based Aryl Piperazines D-264 and D-301 at D2 and D3 Receptors. Neurochemical Research, 1-12. https://doi.org/10.1007/s11064-015-1808-6

    Efficacy of Hybrid Tetrahydrobenzo[d]thiazole Based Aryl Piperazines D-264 and D-301 at D2 and D3 Receptors. / Zhen, Juan; Antonio, Tamara; Jacob, Joanna C.; Grandy, David; Reith, Maarten E A; Dutta, Aloke K.; Selley, Dana E.

    In: Neurochemical Research, 31.12.2015, p. 1-12.

    Research output: Contribution to journalArticle

    Zhen, Juan ; Antonio, Tamara ; Jacob, Joanna C. ; Grandy, David ; Reith, Maarten E A ; Dutta, Aloke K. ; Selley, Dana E. / Efficacy of Hybrid Tetrahydrobenzo[d]thiazole Based Aryl Piperazines D-264 and D-301 at D2 and D3 Receptors. In: Neurochemical Research. 2015 ; pp. 1-12.
    @article{d962a9282fb14975a34bad94dad480e6,
    title = "Efficacy of Hybrid Tetrahydrobenzo[d]thiazole Based Aryl Piperazines D-264 and D-301 at D2 and D3 Receptors",
    abstract = "In elucidating the role of pharmacodynamic efficacy at D3 receptors in therapeutic effectiveness of dopamine receptor agonists, the influence of study system must be understood. Here two compounds with D3 over D2 selectivity developed in our earlier work, D-264 and D-301, are compared in dopamine receptor-mediated G-protein activation in striatal regions of wild-type and D2 receptor knockout mice and in CHO cells expressing D2 or D3 receptors. In caudate-putamen of D2 knockout mice, D-301 was ~3-fold more efficacious than D-264 in activating G-proteins as assessed by [35S]GTPγS binding; in nucleus accumbens, D-301 stimulated G-protein activation whereas D-264 did not. In contrast, the two ligands exerted similar efficacy in both regions of wild-type mice, suggesting both ligands activate D2 receptors with similar efficacy. In D2 and D3 receptor-expressing CHO cells, D-264 and D-301 appeared to act in the [35S]GTPγS assay as full agonists because they produced maximal stimulation equal to dopamine. Competition for [3H]spiperone binding was then performed to determine Ki/EC50 ratios as an index of receptor reserve for each ligand. Action of D-301, but not D-264, showed receptor reserve in D3 but not in D2 receptor-expressing cells, whereas dopamine showed receptor reserve in both cell lines. Gαo1 is highly expressed in brain and is important in D2-like receptor-G protein coupling. Transfection of Gαo1 in D3- but not D2-expressing CHO cells led to receptor reserve for D-264 without altering receptor expression levels. D-301 and dopamine exhibited receptor reserve in D3-expressing cells both with and without transfection of Gαo1. Altogether, these results indicate that D-301 has greater intrinsic efficacy to activate D3 receptors than D-264, whereas the two compounds act on D2 receptors with similar intrinsic efficacy. These findings also suggest caution in interpreting Emax values from functional assays in receptor-transfected cell models without accounting for receptor reserve.",
    keywords = "D, D, Dopamine receptors, G protein, Gα1, Intrinsic efficacy, Rat tissue, [S]GTPγS binding assay",
    author = "Juan Zhen and Tamara Antonio and Jacob, {Joanna C.} and David Grandy and Reith, {Maarten E A} and Dutta, {Aloke K.} and Selley, {Dana E.}",
    year = "2015",
    month = "12",
    day = "31",
    doi = "10.1007/s11064-015-1808-6",
    language = "English (US)",
    pages = "1--12",
    journal = "Neurochemical Research",
    issn = "0364-3190",
    publisher = "Springer New York",

    }

    TY - JOUR

    T1 - Efficacy of Hybrid Tetrahydrobenzo[d]thiazole Based Aryl Piperazines D-264 and D-301 at D2 and D3 Receptors

    AU - Zhen, Juan

    AU - Antonio, Tamara

    AU - Jacob, Joanna C.

    AU - Grandy, David

    AU - Reith, Maarten E A

    AU - Dutta, Aloke K.

    AU - Selley, Dana E.

    PY - 2015/12/31

    Y1 - 2015/12/31

    N2 - In elucidating the role of pharmacodynamic efficacy at D3 receptors in therapeutic effectiveness of dopamine receptor agonists, the influence of study system must be understood. Here two compounds with D3 over D2 selectivity developed in our earlier work, D-264 and D-301, are compared in dopamine receptor-mediated G-protein activation in striatal regions of wild-type and D2 receptor knockout mice and in CHO cells expressing D2 or D3 receptors. In caudate-putamen of D2 knockout mice, D-301 was ~3-fold more efficacious than D-264 in activating G-proteins as assessed by [35S]GTPγS binding; in nucleus accumbens, D-301 stimulated G-protein activation whereas D-264 did not. In contrast, the two ligands exerted similar efficacy in both regions of wild-type mice, suggesting both ligands activate D2 receptors with similar efficacy. In D2 and D3 receptor-expressing CHO cells, D-264 and D-301 appeared to act in the [35S]GTPγS assay as full agonists because they produced maximal stimulation equal to dopamine. Competition for [3H]spiperone binding was then performed to determine Ki/EC50 ratios as an index of receptor reserve for each ligand. Action of D-301, but not D-264, showed receptor reserve in D3 but not in D2 receptor-expressing cells, whereas dopamine showed receptor reserve in both cell lines. Gαo1 is highly expressed in brain and is important in D2-like receptor-G protein coupling. Transfection of Gαo1 in D3- but not D2-expressing CHO cells led to receptor reserve for D-264 without altering receptor expression levels. D-301 and dopamine exhibited receptor reserve in D3-expressing cells both with and without transfection of Gαo1. Altogether, these results indicate that D-301 has greater intrinsic efficacy to activate D3 receptors than D-264, whereas the two compounds act on D2 receptors with similar intrinsic efficacy. These findings also suggest caution in interpreting Emax values from functional assays in receptor-transfected cell models without accounting for receptor reserve.

    AB - In elucidating the role of pharmacodynamic efficacy at D3 receptors in therapeutic effectiveness of dopamine receptor agonists, the influence of study system must be understood. Here two compounds with D3 over D2 selectivity developed in our earlier work, D-264 and D-301, are compared in dopamine receptor-mediated G-protein activation in striatal regions of wild-type and D2 receptor knockout mice and in CHO cells expressing D2 or D3 receptors. In caudate-putamen of D2 knockout mice, D-301 was ~3-fold more efficacious than D-264 in activating G-proteins as assessed by [35S]GTPγS binding; in nucleus accumbens, D-301 stimulated G-protein activation whereas D-264 did not. In contrast, the two ligands exerted similar efficacy in both regions of wild-type mice, suggesting both ligands activate D2 receptors with similar efficacy. In D2 and D3 receptor-expressing CHO cells, D-264 and D-301 appeared to act in the [35S]GTPγS assay as full agonists because they produced maximal stimulation equal to dopamine. Competition for [3H]spiperone binding was then performed to determine Ki/EC50 ratios as an index of receptor reserve for each ligand. Action of D-301, but not D-264, showed receptor reserve in D3 but not in D2 receptor-expressing cells, whereas dopamine showed receptor reserve in both cell lines. Gαo1 is highly expressed in brain and is important in D2-like receptor-G protein coupling. Transfection of Gαo1 in D3- but not D2-expressing CHO cells led to receptor reserve for D-264 without altering receptor expression levels. D-301 and dopamine exhibited receptor reserve in D3-expressing cells both with and without transfection of Gαo1. Altogether, these results indicate that D-301 has greater intrinsic efficacy to activate D3 receptors than D-264, whereas the two compounds act on D2 receptors with similar intrinsic efficacy. These findings also suggest caution in interpreting Emax values from functional assays in receptor-transfected cell models without accounting for receptor reserve.

    KW - D

    KW - D

    KW - Dopamine receptors

    KW - G protein

    KW - Gα1

    KW - Intrinsic efficacy

    KW - Rat tissue

    KW - [S]GTPγS binding assay

    UR - http://www.scopus.com/inward/record.url?scp=84952672083&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84952672083&partnerID=8YFLogxK

    U2 - 10.1007/s11064-015-1808-6

    DO - 10.1007/s11064-015-1808-6

    M3 - Article

    SP - 1

    EP - 12

    JO - Neurochemical Research

    JF - Neurochemical Research

    SN - 0364-3190

    ER -